tiprankstipranks
KP Tissue Inc. (TSE:KPT)
TSX:KPT
Canadian Market
Want to see TSE:KPT full AI Analyst Report?

KP Tissue (KPT) Earnings Dates, Call Summary & Reports

110 Followers

Earnings Data

Report Date
Aug 06, 2026
Before Open (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
0.26
Last Year’s EPS
-1.36
Same Quarter Last Year
Based on 1 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 18, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: double-digit adjusted EBITDA growth, revenue gains, market-share expansion in Canada, a net income turnaround and improved liquidity and leverage. Challenges include modest sequential softness in revenue and EBITDA, rising operating and SG&A costs, pulp price volatility with potential upward pressure in 2026, and higher planned CapEx with possible short-term leverage increases tied to a new TAD project. On balance, the positive performance metrics and strategic progress outweigh the near-term headwinds.
Company Guidance
Management guided Q1 2026 adjusted EBITDA to be in a similar range to Q4 2025 (Q4 adjusted EBITDA $84.2M; run rate above $80M for a second consecutive quarter) with consolidated adjusted EBITDA margin ~15% (consumer margin 16.5%, AFH margin 11%). They raised 2026 CapEx to $100–$120M (FY2025 CapEx $78M; Q4 CapEx $33.4M), with base CapEx ~$50–70M, Line 11 spending $25–35M and a small amount of first‑year TAD project spend. The new converting line in Memphis is on track for early Q2 2026 start, a proposed Western U.S. TAD plant is slated to open in 2028 with a detailed announcement expected H1 2026, and financing could push leverage briefly above 4x (current leverage 3.1x; long‑term debt $1.741B; cash $196.1M; net debt reduced by $55.7M). Management will monitor pulp and other input costs (Q4 pulp QoQ range -6.6% to +3.3%; NBSK -7.3% YoY; BEK -5.3% YoY) and use its pricing model to respond as needed.
Adjusted EBITDA Growth and Margin Improvement
Q4 adjusted EBITDA of $84.2M, up 26% year-over-year; adjusted EBITDA margin improved to 15.0% from 12.4% a year ago; run-rate above $80M for a second consecutive quarter.
Revenue Growth
Q4 consolidated revenue of $560.1M, up 3.8% year-over-year (described as nearly 4%); full fiscal 2025 revenue growth of 7.5%.
Net Income Turnaround
Q4 net income of $23.4M versus a net loss of $13.7M in Q4 2024; improvement driven by favorable foreign exchange of $29.7M and higher adjusted EBITDA of $17.4M (partially offset by tax, interest and noncontrolling interest impacts).
Geographic Performance — Canada and U.S.
Canada Q4 revenue +5.1% (approx. +$15M); U.S. Q4 revenue +2.2% (approx. +$5.5M) despite a strong prior-year comparable; U.S. annual growth rate of 8.2%, identified as the company’s growth engine.
Strong Consumer and AFH Segment Results
Consumer revenue $472.3M, up 4.3% YoY; consumer adjusted EBITDA $78.1M with a 16.5% margin (improvement of ~2 percentage points YoY). Away-From-Home revenue $87.8M, up 1% YoY; AFH adjusted EBITDA $9.7M vs $4.6M YoY, AFH margin ~11% (more than doubled year-over-year).
Market Share Gains in Canada
Facial tissue market share increased by 130 basis points to 46.3% (52-week period ended Dec 27, 2025); paper towel share grew 130 basis points to 25.3%; bathroom tissue showed incremental year-over-year growth.
Operational Progress and Safety
Positive production rates across paper machine and converting operations; Memphis converting line on track for startup in early Q2 2026; Sherbrooke in-sourcing improved AFH margins; record safety results across manufacturing assets in 2025.
Balance Sheet and Liquidity Improvement
Cash improved to $196.1M from $149.1M at end of Q3; long-term debt of $1.741B decreased $9.4M sequentially; net debt reduced by $55.7M; leverage ratio declined to 3.1x from 3.4x.

KP Tissue (TSE:KPT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TSE:KPT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 06, 2026
2026 (Q2)
0.26 / -
-1.362
May 14, 2026
2026 (Q1)
0.23 / 0.22
0.13562.96% (+0.08)
Feb 18, 2026
2025 (Q4)
0.25 / 0.60
0.34475.29% (+0.26)
Nov 13, 2025
2025 (Q3)
0.14 / 0.84
-0.818202.20% (+1.65)
Aug 13, 2025
2025 (Q2)
0.12 / -1.36
0.516-363.95% (-1.88)
May 14, 2025
2025 (Q1)
0.09 / 0.14
1.097-87.69% (-0.96)
Mar 05, 2025
2024 (Q4)
0.15 / 0.34
-0.819142.00% (+1.16)
Nov 13, 2024
2024 (Q3)
0.14 / -0.82
0.32-355.62% (-1.14)
Aug 13, 2024
2024 (Q2)
0.19 / 0.52
0.3261.25% (+0.20)
May 14, 2024
2024 (Q1)
0.11 / 1.10
-0.998209.92% (+2.09)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

TSE:KPT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 14, 2026
C$11.50C$11.59+0.78%
Feb 18, 2026
C$10.47C$10.51+0.38%
Nov 13, 2025
C$9.11C$9.18+0.85%
Aug 13, 2025
C$8.96C$9.01+0.64%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does KP Tissue Inc. (TSE:KPT) report earnings?
KP Tissue Inc. (TSE:KPT) is schdueled to report earning on Aug 06, 2026, Before Open (Confirmed).
    What is KP Tissue Inc. (TSE:KPT) earnings time?
    KP Tissue Inc. (TSE:KPT) earnings time is at Aug 06, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TSE:KPT EPS forecast?
          TSE:KPT EPS forecast for the fiscal quarter 2026 (Q2) is 0.26.